Global Blood Gas And Electrolyte Analyzer Market Overview 2023-2028
The global blood gas and electrolyte analyzer market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.41% during 2023-2028.
A blood gas and electrolyte analyzer is a medical instrument used to measure the levels of blood gases, such as oxygen and carbon dioxide, and the concentrations of electrolytes like sodium, potassium, and calcium in the blood. It relies on a small blood sample, often taken from an artery, which is then inserted into the device for analysis. It is crucial for assessing the respiratory, metabolic, and renal status of the patient. It is used in critical care settings, such as intensive care units (ICUs) and emergency departments, where rapid and accurate assessment of the blood chemistry of a patient is crucial for diagnosis and treatment.
Global Blood Gas And Electrolyte Analyzer Market Trends and Drivers:
The growing prevalence of chronic conditions, such as kidney diseases, diabetes, and cardiovascular disorders, represents one of the primary factors driving the demand for blood gas and electrolyte analyzers around the world. In addition, the increasing emphasis on point-of-care (POC) testing for quick and effective treatment decisions is catalyzing the adoption of compact and portable blood gas and electrolyte analyzers worldwide. Apart from this, the rising public awareness about the importance of early diagnosis and timely treatment and the implementation of stringent healthcare regulations about diagnostic accuracy are propelling the growth of the market.
Global Blood Gas And Electrolyte Analyzer Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Abbott Laboratories Inc., Dalko Diagnostics, Erba Group (Transasia Bio-Medicals Ltd.), Medica Corporation, Nova Biomedical Corporation, OPTI Medical Systems Inc. (IDEXX Laboratories), Radiometer Medical ApS (Danaher Corporation), Roche Holding AG, Siemens AG, and WerfenLife S.A.
The report segmented the market on the basis of region, product type, modality and end user.
Breakup by Product Type:
- Analyzers
- Consumables
Breakup by Modality:
- Benchtop
- Portable
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
